New drug aims to supercharge walking recovery after spinal cord injury
Disease control
Not yet recruiting
This study tests whether a drug called istradefylline can boost the walking improvements seen with low-oxygen therapy in people with chronic, incomplete spinal cord injury. About 40 adults aged 18-75 with injuries at least one year old will receive the drug or a placebo before wa…
Phase: PHASE1, PHASE2 • Sponsor: Randy Trumbower, PT, PhD • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC